Brian Burke is a partner in Baker McKenzie’s Washington, DC office. He draws on over 20 years of experience to counsel clients on all federal antitrust issues. He assists clients in successfully navigating the merger clearance process before the US as well as international antitrust authorities. Brian also has extensive experience advising clients on civil and criminal governmental antitrust investigations, commercial antitrust litigation, antitrust compliance programs, risk assessments, and pricing and distribution policies. Brian holds multiple leadership positions in the Firm. He is a member of the Steering Committee for the Firm’s North American Antitrust Practice Group, as well of the Global Antitrust and Competition Taskforces for Healthcare, Energy Mining and Infrastructure, and Consumer Goods Industries. He also serves as the co-head of the Firm’s Merger-Control Task Force.
92
In brief In a notable turn of events, the Federal Trade Commission (FTC) announced that it would abandon its in-house post-consummation challenge of the 2018 acquisition by Axon Enterprise, Inc. (“Axon”) of VieVu, LLC (“VieVu”). The FTC’s decision follows a recent adverse ruling from the (...)
336
In brief The US Federal Trade Commission (FTC) and the US Department of Justice Antitrust Division (DOJ) (together "Agencies") each have recently taken enforcement actions that demonstrate renewed attention on interlocking directorates (in which individuals simultaneously serve as directors (...)
48
In brief On Tuesday, 27 June 2023, the Federal Trade Commission (FTC), with the concurrence of the Assistant Attorney General for the US Department of Justice’s Antitrust Division (DOJ), announced proposed changes to the premerger notification form and associated instructions and rules that (...)
